Becton, dickinson and company:1106636 [17-029137]
Ended Awarded
- Contract number
- HHSN26100045
- Awardee
-
Becton, Dickinson And Company UEI MM5ZHL8SRFY5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,866
Award facts
- Opportunity
-
- N02RC4256357 Solicitation number
- Flow Cytometric Analysis of Benign and Malignant Tumors. Award Notice · Posted Jun 30, 2014
- Contract value 100% obligated
- $9,865.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- 6810 Chemicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN26100045?
HHSN26100045 was awarded to Becton, Dickinson And Company by National Cancer Institute (National Institutes of Health) on March 15, 2017.
How much is contract HHSN26100045 worth?
The government has obligated $9,866 on HHSN26100045.
Is contract HHSN26100045 an order under another contract?
Yes. HHSN26100045 is a delivery order under HHSN261201400013I, an indefinite delivery contract.
Was contract HHSN26100045 competed?
The extent of competition for HHSN26100045 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award